Policy
-
April 30: The Week in Cancer NewsPresident Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.
by Bradley Jones
-
Forward Look
Making Cancer Clinical Trials More InclusiveDespite efforts by policymakers, a gender gap persists in clinical trial participation.
by Lindsey Konkel
-
Policy Matters
Research Advocacy During COVID-19Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
-
Q&A
Up for DebateHematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Cancer and COVID-19 VaccinationAmid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Colorectal Cancer Screenings at HomeStool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
-
Forward Look
Creating More Inclusive Clinical TrialsThe Clinical Treatment Act aims to include more Medicaid recipients.
by Jen Tota McGivney
-
Policy Matters
The E-Cigarette Regulatory LandscapeThe FDA is taking several steps to restrict and reduce e-cigarette use among youth.
by Carmine S. Leggett, PhD
